Intensive care of the patient following open abdominal aortic surgery

Current Opinion in Critical Care

Volumn 12, Issue 4, 2006, Pages 340-345

  Papia, Giuseppe ^a,b   Klein, David ^a,c   Lindsay, Thomas F ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Abdominal aortic aneurysm; Intensive care unit; Postoperative medical treatment; Vascular surgery

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; FENOLDOPAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; PARECOXIB; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT ERYTHROPOIETIN; TROPONIN I; VASODILATOR AGENT;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; AORTA SURGERY; APACHE; BETA ADRENERGIC RECEPTOR BLOCKING; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COLON ISCHEMIA; COLONOSCOPY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DOPPLER FLOWMETRY; EMERGENCY SURGERY; EPIDURAL ANESTHESIA; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HEMODYNAMICS; HIGH RISK BEHAVIOR; HUMAN; HYPOTHERMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; ISCHEMIC COLITIS; KIDNEY FAILURE; MORBIDITY; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTION; REVIEW; SIGMOIDOSCOPY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THROMBOSIS; TRACHEOSTOMY;

AORTIC ANEURYSM, ABDOMINAL; HUMANS; INTENSIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 33746042187     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/01.ccx.0000235212.86859.54     Document Type: Review

References (54)

1. Svensson LG, Rodriguez ER. Aortic organ disease epidemic, and why do balloons pop? Circulation 2005; 112:1082-1084. This is a quick editorial that nicely outlines the epidemiology of this disease process, and new exciting research developments.
2. Gillum RF. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol 1995; 48:1289-1298.
3. Anidjar S, Kieffer E. Pathogenesis of acquired aneurysms of the abdominal aorta. Ann Vasc Surg 1992; 6:298-305.
4. Lederle FA, Wilson SE, Johnson GR, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346:1437-1444.
5. Vemuri C, Wainess RM, Dimick JB, et al. Effect of increasing patient age on complication rates following intact abdominal aortic aneurysm repair in the United States. J Surg Res 2004; 118:26-31.
6. Bown MJ, Sutton AJ, Bell PR, Sayers RD. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 2002; 89:714-730.
7. Gopalan PD, Burrows RC. Critical care of the vascular surgery patient. Crit Care Clin 2003; 19:109-125.
8. Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995; 82:1026-1060.
9. Roizen MF, Beaupre PN, Alpert RA, et al. Monitoring with two-dimensional transesophageal echocardiography. Comparison of myocardial function in patients undergoing supraceliac, suprarenal-infraceliac, or infrarenal aortic occlusion. J Vasc Surg 1984; 1:300-305.
10. Alpert RA, Roizen MF, Hamilton WK, et al. Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 1984; 95:707-711.
11. Back MR, Leo F, Cuthbertson D, et al. Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg 2004; 40:752-760.
12. Hadjianastassiou VG, Tekkis PP, Goldhill DR, Hands LJ. Quantification of mortality risk after abdominal aortic aneurysm repair. Br J Surg 2005; 92:1092-1098. A large, well designed study attempting to articulate an accurate risk-stratification model for both elective and emergent aortic aneurysm repair.
13. Laukontaus SJ, Lepantalo M, Hynninen M, et al. Prediction of survival after 48-h of intensive care following open surgical repair of ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2005; 30:509-515. A small, retrospective study with an excellent discussion on specific factors influencing outcome after ruptured AAA.
14. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353:349-361. A very large, retrospective cohort study with propensity scoring for covariate adjustment. It has a good discussion on different risk groups with a thoughtful accompanying editorial.
15. Le Manach Y, Perel A, Coriat P, et al. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005; 102:885-891. A well designed, large study describing the importance of following cardiac troponin I after abdominal aortic surgery and the pathophysiology of post-op myocardial infarction.
16. Tambyraja AL, Dawson AR, Murie JA, Chalmers RT. Cardiac troponin I predicts outcome after ruptured abdominal aortic aneurysm repair. Br J Surg 2005; 92:824-827. A small study outlining the utility of following cardiac troponin I after ruptured AAA repair.
17. Kertai MD, Boersma E, Klein J, et al. Optimizing the prediction of perioperative mortality in vascular surgery by using a customized probability model. Arch Intern Med 2005; 165:898-904. Interesting statistical modeling was used in this study on a large number of patients to estimate perioperative all-cause mortality after noncardiac vascular surgery.
18. Diedrich DA, Keegan MT, Brown DR. Tracheostomy after major vascular surgery. J Cardiothorac Vasc Anesth 2006; 20:14-19. A detailed look at tracheostomy as a maker for outcome in this population. It is the first paper to describe a possible benefit in patients with chronic obstructive pulmonary disease after AAA repair.
19. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72:153-184.
20. Hertzer NR, Young JR, Kramer JR, et al. Routine coronary angiography prior to elective aortic reconstruction: results of selective myocardial revascularization in patients with peripheral vascular disease. Arch Surg 1979; 114:1336-1344.
21. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
22. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39:542-553.
23. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97:623-633.
24. Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001; 141:148-153.
25. Smout J, Stansby G. Current practice in the use of antiplatelet agents in the peri-operative period by UK vascular surgeons. Ann R Coll Surg Engl 2003; 85:97-101.
26. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005; 45:336-342. This is a retrospective study that is well focused on the vascular surgery population.
27. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142:510-524. This meta-analysis represents the most comprehensive compilation on 'renal-dose' dopamine to date.
28. Halpenny M, Rushe C, Breen P, et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002; 19:32-39.
29. Miller Q, Peyton BD, Cohn EJ, et al. The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. Ann Vasc Surg 2003; 17:656-662.
30. Burns KE, Chu MW, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA 2005; 294:342-350. A negative study, but a large and well conducted randomized controlled trial of N-acetylcysteine for cardiac surgery patients.
31. Macedo E, Abdulkader R, Castro I, et al. Lack of protection of N-acetylcysteine (NAC) in the acute renal failure related to elective aortic aneurysm repair - a randomized controlled trial. Nephrol Dial Transplant 2006 (epub ahead of print). This study is the only direct evidence against the use of N-acetylcysteine in aortic aneurysm patients.
32. Hauser B, Froba G, Bracht H, et al. Effects of intrarenal administration of the cox-2 inhibitor parecoxib during porcine suprarenal aortic cross-clamping. Shock 2005; 24:476-481. A very preliminary animal study investigating a potential future avenue of therapy.
33. Freedman J, Luke K, Monga N, et al. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apher Sci 2005; 33:343-349. This paper details a novel systematic approach for decreasing the use of allogeneic blood. This program has been very effective to date.
34. Szalay D, Wong D, Lindsay T. Impact of red cell salvage on transfusion requirements during elective abdominal aortic aneurysm repair. Ann Vasc Surg 1999; 13:576-581.
35. Sarac TP, Clifford C, Waters J, et al. Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. J Vasc Surg 2003; 37:453-455.
36. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288:2827-2835.
37. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417.
38. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29:227-234.
39. Manning BJ, Hynes N, Courtney DF, Sultan S. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. Eur J Vasc Endovasc Surg 2005; 30:525-527. This case series is the largest to date of the use of Factor VIIa in vascular surgery patients.
40. Connors AF Jr, Speroff T, Dwson NV, et al. for the SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996; 276:880-897.
41. Polanczyk CA, Rohde LE, Goldman L, et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA 2001; 286:309-314.
42. Sandham JD, Hull RD, Brant RF, et al. for the Canadian Critical Care Trials Group. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14.
43. Rivers E, Nguyen B, Havstad S, et al. for the Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
44. Pearse R, Dawson D, Fawcett J, et al. Early goal-directedf therapy after major surgery reduces complication and duration of hospital stay. A randomized controlled trial. Crit Care 2005; 9:R687-R693. A small but successful trial of an early goal-directed strategy in postoperative care. A nice algorithm is included that could be adapted for local practice.
45. Gopalan PD, Burrows RC. Critical care of the vascular surgery patient. Crit Care Clin 2003; 19:109-125.
46. Avrahami R, Cohen JD, Haddad M, et al. Gastric emptying after elective abdominal aortic aneurysm surgery: the case for early postoperative enteral feeding. Eur J Vasc Endovasc Surg 1999; 17:241-244.
47. Fraser RJ, Ritz M, Di Matteo AC, et al. Distal small bowel motility and lipid absorption in patients following abdominal aortic aneurysm repair surgery. World J Gastroenterol 2006; 12:582-587.
48. Kehlet H, Moesgaard F. Prophylaxis against postoperative complications in gastroenterology. Scand J Gastroenterol Suppl 1996; 216:218-224.
49. Champagne BJ, Darling RC 3rd, Daneshmand M, et al. Outcome of aggressive surveillance colonoscopy in ruptured abdominal aortic aneurysm. J Vasc Surg 2004; 39:792-796.
50. Mitchell KM, Valentine RJ. Inferior mesenteric artery reimplantation does not guarantee colon viability in aortic surgery. J Am Coll Surg 2002; 194:151-155.
51. Bjorck M, Lindberg F, Broman G, Bergqvist D. pHi monitoring of the sigmoid colon after aortoiliac surgery A five-year prospective study. Eur J Vasc Endovasc Surg 2000; 20:273-280.
52. Bastounis E, Filis K, Georgopoulos S, et al. Selective use of the intensive care unit after elective infrarenal abdominal aortic aneurysm repair. Int Angiol 2003; 22:308-316.
53. Lawlor DK, Lovell MB, DeRose G, et al. Is intensive care necessary after elective abdominal aortic aneurysm repair? Can J Surg 2004; 47:359-363.
54. Pronovost PJ, Jenckes MW, Dorman T, et al. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999; 281:1310-1317.